AeroLeads people directory · profile

Phil Chamberlain Email & Phone Number

Biotechnology leader in new modalities and targeted protein degradation at Neomorph, Inc.
Location: San Diego, California, United States 6 work roles 2 schools
1 work email found @neomorph.com 1 phone found area 908 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 1 phone

Work email p****@neomorph.com
Direct phone (908) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Biotechnology leader in new modalities and targeted protein degradation
Location
San Diego, California, United States

Who is Phil Chamberlain? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Phil Chamberlain is listed as Biotechnology leader in new modalities and targeted protein degradation at Neomorph, Inc., based in San Diego, California, United States. AeroLeads shows a work email signal at neomorph.com, phone signal with area code 908, and a matched LinkedIn profile for Phil Chamberlain.

Phil Chamberlain previously worked as Co-Founder, President and CEO at Neomorph, Inc. and Executive Director, Protein Homeostasis and Structural Biology at Bristol-Myers Squibb. Phil Chamberlain holds D.Phil., Structural Biology from University Of Oxford.

Company email context

Email format at Neomorph, Inc.

This section adds company-level context without repeating Phil Chamberlain's masked contact details.

{first}@neomorph.com
86% confidence

AeroLeads found 1 current-domain work email signal for Phil Chamberlain. Compare company email patterns before reaching out.

Profile bio

About Phil Chamberlain

With a background in structural and chemical biology, I have focused on pushing the boundaries of new modalities such as targeted protein degradation to enable the discovery of advanced new therapeutics. Published breakthroughs include the first structure of thalidomide bound to human cereblon, the discovery of the molecular feature required for the recruitment and destruction of first generation 'neosubstrates', demonstration that cereblon could be repurposed via 'molecular glue' to degrade novel neosubstrates such as GSPT1, and a molecular explanation for the thalidomide teratogenicity tragedy of the 20th century.

Listed skills include Drug Discovery, Biochemistry, Protein Chemistry, Structural Biology, and 13 others.

Current workplace

Phil Chamberlain's current company

Company context helps verify the profile and gives searchers a useful next step.

Neomorph, Inc.
Neomorph, Inc.
Biotechnology leader in new modalities and targeted protein degradation
AeroLeads page
6 roles · 28 years

Phil Chamberlain work experience

A career timeline built from the work history available for this profile.

Co-Founder, President And Ceo

Current

San Diego, CA, US

After working in the molecular glue field of drug discovery for roughly a decade, I took the chance to co-found a company specializing in this approach. Molecular glue drugs can trigger the degradation of proteins in ways that don't conform to the rules of other drug modalities, enabling them to be used to tackle 'undruggable' proteins linked to disease..

Feb 2020 - Present

Executive Director, Protein Homeostasis And Structural Biology

Lawrence Township, NJ, US

Nov 2019 - Feb 2020

Executive Director

Summit, New Jersey, US

At Celgene I lead the Structural and Chemical Biology department. The mission was to enable and support drug discovery projects by identifying chemical matter using biochemical and cellular assays, and providing structural biology information and expertise. We further established Celgene expertise in the novel modality of targeted protein degradation.

Dec 2007 - Nov 2019

Postdoctoral Associate / Institute Fellow

San Diego, CA, US

My work at the GNF focused on the development of structural and biochemical approaches against novel enzyme drug targets. At the GNF I proposed and lead a small molecule discovery program against a novel target in serious respiratory disease. I also participated in further project teams as a crystallographer, solving novel structures in the area of serious.

2004 - 2007 ~3 yrs

Howard Hughes Undergraduate Fellow

Mount Sinai School Of Medicine
1998 - 1998
2 education records

Phil Chamberlain education

D.Phil., Structural Biology

University Of Oxford

Ba, Biological Sciences

University Of Oxford
FAQ

Frequently asked questions about Phil Chamberlain

Quick answers generated from the profile data available on this page.

What company does Phil Chamberlain work for?

Phil Chamberlain works for Neomorph, Inc..

What is Phil Chamberlain's role at Neomorph, Inc.?

Phil Chamberlain is listed as Biotechnology leader in new modalities and targeted protein degradation at Neomorph, Inc..

What is Phil Chamberlain's email address?

AeroLeads has found 1 work email signal at @neomorph.com for Phil Chamberlain at Neomorph, Inc..

What is Phil Chamberlain's phone number?

AeroLeads has found 1 phone signal(s) with area code 908 for Phil Chamberlain at Neomorph, Inc..

Where is Phil Chamberlain based?

Phil Chamberlain is based in San Diego, California, United States while working with Neomorph, Inc..

What companies has Phil Chamberlain worked for?

Phil Chamberlain has worked for Neomorph, Inc., Bristol-Myers Squibb, Celgene, Genomics Institute Of The Novartis Research Foundation, and University Of Oxford.

How can I contact Phil Chamberlain?

You can use AeroLeads to view verified contact signals for Phil Chamberlain at Neomorph, Inc., including work email, phone, and LinkedIn data when available.

What schools did Phil Chamberlain attend?

Phil Chamberlain holds D.Phil., Structural Biology from University Of Oxford.

What skills is Phil Chamberlain known for?

Phil Chamberlain is listed with skills including Drug Discovery, Biochemistry, Protein Chemistry, Structural Biology, High Throughput Screening, Molecular Biology, Assay Development, and Enzyme Assays.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.